Liabilities and Equity of INFINITY PHARMACEUTICALS, INC. from 31 Dec 2010 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
- Summary
-
INFINITY PHARMACEUTICALS, INC. quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2010 to 30 Jun 2023.
- INFINITY PHARMACEUTICALS, INC. Liabilities and Equity for the quarter ending 30 Jun 2023 was $21,232,000, a 66% decline year-over-year.
- Source SEC data
- View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)
INFINITY PHARMACEUTICALS, INC. Quarterly Liabilities and Equity (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | $21,232,000 | -$40,625,000 | -66% | 30 Jun 2023 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $29,951,000 | -$42,627,000 | -59% | 31 Mar 2023 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2022 | $42,151,000 | -$42,634,000 | -50% | 31 Dec 2022 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q3 2022 | $51,591,000 | -$43,024,000 | -45% | 30 Sep 2022 | 10-Q | 14 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $61,857,000 | -$40,741,000 | -40% | 30 Jun 2022 | 10-Q | 09 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $72,578,000 | -$39,820,000 | -35% | 31 Mar 2022 | 10-Q | 03 May 2022 | 2022 | Q1 |
| Q4 2021 | $84,785,000 | +$45,466,000 | +116% | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY |
| Q3 2021 | $94,615,000 | +$47,650,000 | +101% | 30 Sep 2021 | 10-Q | 02 Nov 2021 | 2021 | Q3 |
| Q2 2021 | $102,598,000 | +$53,942,000 | +111% | 30 Jun 2021 | 10-Q | 27 Jul 2021 | 2021 | Q2 |
| Q1 2021 | $112,398,000 | +$55,310,000 | +97% | 31 Mar 2021 | 10-Q | 13 May 2021 | 2021 | Q1 |
| Q4 2020 | $39,319,000 | -$9,695,000 | -20% | 31 Dec 2020 | 10-K | 29 Mar 2022 | 2021 | FY |
| Q3 2020 | $46,965,000 | -$12,143,000 | -21% | 30 Sep 2020 | 10-Q | 09 Nov 2020 | 2020 | Q3 |
| Q2 2020 | $48,656,000 | -$19,782,000 | -29% | 30 Jun 2020 | 10-Q | 30 Jul 2020 | 2020 | Q2 |
| Q1 2020 | $57,088,000 | -$17,657,000 | -24% | 31 Mar 2020 | 10-Q | 11 May 2020 | 2020 | Q1 |
| Q4 2019 | $49,014,000 | -$11,201,000 | -19% | 31 Dec 2019 | 10-K | 16 Mar 2021 | 2020 | FY |
| Q3 2019 | $59,108,000 | -$6,805,000 | -10% | 30 Sep 2019 | 10-Q | 30 Oct 2019 | 2019 | Q3 |
| Q2 2019 | $68,438,000 | +$17,172,000 | +33% | 30 Jun 2019 | 10-Q | 30 Jul 2019 | 2019 | Q2 |
| Q1 2019 | $74,745,000 | +$24,779,000 | +50% | 31 Mar 2019 | 10-Q | 07 May 2019 | 2019 | Q1 |
| Q4 2018 | $60,215,000 | +$862,000 | +1.5% | 31 Dec 2018 | 10-K | 03 Mar 2020 | 2019 | FY |
| Q3 2018 | $65,913,000 | +$1,642,000 | +2.6% | 30 Sep 2018 | 10-Q | 05 Nov 2018 | 2018 | Q3 |
| Q2 2018 | $51,266,000 | -$39,579,000 | -44% | 30 Jun 2018 | 10-Q | 07 Aug 2018 | 2018 | Q2 |
| Q1 2018 | $49,966,000 | -$53,641,000 | -52% | 31 Mar 2018 | 10-Q | 08 May 2018 | 2018 | Q1 |
| Q4 2017 | $59,353,000 | -$66,302,000 | -53% | 31 Dec 2017 | 10-K | 14 Mar 2019 | 2018 | FY |
| Q3 2017 | $64,271,000 | -$87,631,000 | -58% | 30 Sep 2017 | 10-Q | 07 Nov 2017 | 2017 | Q3 |
| Q2 2017 | $90,845,000 | -$96,445,000 | -51% | 30 Jun 2017 | 10-Q | 03 Aug 2017 | 2017 | Q2 |
| Q1 2017 | $103,607,000 | -$136,893,000 | -57% | 31 Mar 2017 | 10-Q | 09 May 2017 | 2017 | Q1 |
| Q4 2016 | $125,655,000 | -$163,166,000 | -56% | 31 Dec 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q3 2016 | $151,902,000 | -$181,324,000 | -54% | 30 Sep 2016 | 10-Q | 09 Nov 2016 | 2016 | Q3 |
| Q2 2016 | $187,290,000 | -$53,588,000 | -22% | 30 Jun 2016 | 10-Q | 09 Aug 2016 | 2016 | Q2 |
| Q1 2016 | $240,500,000 | -$27,142,000 | -10% | 31 Mar 2016 | 10-Q | 04 May 2016 | 2016 | Q1 |
| Q4 2015 | $288,821,000 | -$80,323,000 | -22% | 31 Dec 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q3 2015 | $333,226,000 | -$63,599,000 | -16% | 30 Sep 2015 | 10-Q | 05 Nov 2015 | 2015 | Q3 |
| Q2 2015 | $240,878,000 | +$75,293,000 | +45% | 30 Jun 2015 | 10-Q | 06 Aug 2015 | 2015 | Q2 |
| Q1 2015 | $267,642,000 | +$67,861,000 | +34% | 31 Mar 2015 | 10-Q | 06 May 2015 | 2015 | Q1 |
| Q4 2014 | $369,144,000 | +$138,434,000 | +60% | 31 Dec 2014 | 10-K | 23 Feb 2016 | 2015 | FY |
| Q3 2014 | $396,825,000 | +$136,013,000 | +52% | 30 Sep 2014 | 10-Q | 10 Nov 2014 | 2014 | Q3 |
| Q2 2014 | $165,585,000 | -$122,138,000 | -42% | 30 Jun 2014 | 10-Q | 11 Aug 2014 | 2014 | Q2 |
| Q1 2014 | $199,781,000 | -$113,712,000 | -36% | 31 Mar 2014 | 10-Q | 06 May 2014 | 2014 | Q1 |
| Q4 2013 | $230,710,000 | -$104,950,000 | -31% | 31 Dec 2013 | 10-K | 24 Feb 2015 | 2014 | FY |
| Q3 2013 | $260,812,000 | +$62,621,000 | +32% | 30 Sep 2013 | 10-Q | 07 Nov 2013 | 2013 | Q3 |
| Q2 2013 | $287,723,000 | +$174,674,000 | +155% | 30 Jun 2013 | 10-Q | 08 Aug 2013 | 2013 | Q2 |
| Q1 2013 | $313,493,000 | +$198,569,000 | +173% | 31 Mar 2013 | 10-Q | 07 May 2013 | 2013 | Q1 |
| Q4 2012 | $335,660,000 | +$211,170,000 | +170% | 31 Dec 2012 | 10-K | 25 Feb 2014 | 2013 | FY |
| Q3 2012 | $198,191,000 | +$100,486,862 | +103% | 30 Sep 2012 | 10-Q | 06 Nov 2012 | 2012 | Q3 |
| Q2 2012 | $113,049,000 | +$8,244,310 | +7.9% | 30 Jun 2012 | 10-Q | 07 Aug 2012 | 2012 | Q2 |
| Q1 2012 | $114,924,000 | 31 Mar 2012 | 10-Q | 08 May 2012 | 2012 | Q1 | ||
| Q4 2011 | $124,490,000 | -$75,922 | -0.06% | 31 Dec 2011 | 10-K | 05 Mar 2013 | 2012 | FY |
| Q3 2011 | $97,704,138 | 30 Sep 2011 | 10-Q | 08 Nov 2011 | 2011 | Q3 | ||
| Q2 2011 | $104,804,690 | 30 Jun 2011 | 10-Q | 09 Aug 2011 | 2011 | Q2 | ||
| Q4 2010 | $124,565,922 | 31 Dec 2010 | 10-K | 13 Mar 2012 | 2011 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.